𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression is strongly induced by ACTH in adrenocortical cells

✍ Scribed by Nicolas Quirin; Michelle Keramidas; Jérôme Garin; Edmond Chambaz; Jean-Jacques Feige


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
214 KB
Volume
180
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Besides its acute and chronic effects on corticosteroid synthesis, the pituitary adrenocorticotropic hormone (ACTH) regulates diverse adrenocortical biological functions including the synthesis of a number of mitochondrial, cytoplasmic, and secreted proteins. ACTH-induced secreted proteins are candidates to act as local extracellular relays of the hormone in either an autocrine or a paracrine manner.

In the present study, we report that stimulation of primary cultures of bovine adrenocortical (BAC) fasciculata cells with 10 nM ACTH for 24 h results in a mean 8 Ϯ 4-fold induction of the synthesis of a secreted protein presenting an apparent Mr of 21 kDa. Peptide microsequencing and Western blotting allowed us to identify this 21-kDa ACTH-induced protein as the tissue inhibitor of metalloproteinase-2 (TIMP-2). The induction of TIMP-2 by ACTH required transcription, was mimicked by 8-bromo cyclic 3Ј-5Ј adenosine monophosphate, but was not observed in response to angiotensin II, IGF-1, fibroblast growth factor-2, transforming growth factor-␤1, or cortisol treatments. ACTH stimulated TIMP-2 mRNA levels by a factor 4, whereas TIMP-1 mRNA levels were not affected and TIMP-3 mRNA remained undetectable. The biological activity of TIMP-2 varied accordingly, as we observed that the conditioned medium of ACTH-treated BAC cells was four times more potent at inhibiting gelatinolytic activity than was the conditioned medium of control cells. Because the proteolytic activity of both progelatinase-B and progelatinase-A secreted by BAC cells remained latent, whether in the presence or in the absence of ACTH, a paracrine rather than autocrine role is proposed for TIMP-2 in the adrenal cortex.


📜 SIMILAR VOLUMES


Cloning, expression, and characterizatio
✍ Ronald T. Aimes; Ling-Hui Li; Brian Weaver; Susan Hawkes; Elizabeth A. Hahn-Dant 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

Rous sarcoma virus-transformed chicken embryo fibroblasts (RSVCEF), when compared to normal CEF, produce elevated levels of matrix metalloproteinase-2 (MMP-2) that exists in a form free of complexed tissue inhibitor of metalloproteinase-2 (TIMP-2). In order to ascertain whether the increased levels

Expression of tissue inhibitor of matrix
✍ Tomokazu Yoshizaki; Yumiko Maruyama; Hiroshi Sato; Mitsuru Furukawa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 321 KB 👁 2 views

Matrix metalloproteinase 2 (MMP-2) plays a crucial role in invasion and metastasis of malignant tumors. Membrane type 1-MMP (MT1-MMP) was originally identified as an activator of MMP-2. Tissue inhibitor of MMP-2 (TIMP-2) was identified as an inhibitor of MMP-2 and MT1-MMP. However, TIMP-2 was report

Differential expression of Id genes in m
✍ Cathleen L. Cooper; Peter E. Newburger 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

Hematopoietic development is regulated by a complex mixture of cytokine growth factors that guide growth and differentiation of progenitor cell populations at different stages in their development. The genetic programs that drive this process are controlled at the molecular level by the type and num

IL-12- and IL-2-induced tumor regression
✍ Giovana R. Thomas; Zhong Chen; Ileana Enamorado; Caren Bancroft; Carter Van Waes 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 313 KB 👁 2 views

Therapy with IL-12 or IL-2 induces tumor regression in only a few patients with head-and-neck squamous cell carcinoma (SCC), and the factors promoting responsiveness have not been well defined. In this study, we examined whether combined IL-12 and IL-2 therapy can induce tumor regression in a new mu